Gen9 gets $25M in equity funding for DNA synthesis
July 31, 2014 at 07:28 AM EDT
Gen9, a Cambridge-based synthetic biology co-founded in 2009 by Harvard professor George Church, has filed for the receipt of $25 million in equity...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|